Progenity's stock is up 4.9% after securing four patents for ingestible technologiesMarket Watch • 10/13/21
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company's Intellectual Property Position in Ingestible Therapeutics TechnologiesGlobeNewsWire • 10/13/21
PROG Stock: 7 Things to Know About Biotech Penny Stock Progenity as Shares Rocket TodayInvestorPlace • 10/11/21
Progenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq RulesGlobeNewsWire • 10/06/21
Progenity Announces $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq RulesGlobeNewsWire • 10/04/21
Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to PopInvestorPlace • 10/04/21
5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical PlaysBenzinga • 10/04/21